• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者疾病严重程度与炎症相关参数的相关性分析:一项回顾性研究。

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.

机构信息

Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

BMC Infect Dis. 2020 Dec 21;20(1):963. doi: 10.1186/s12879-020-05681-5.

DOI:10.1186/s12879-020-05681-5
PMID:33349241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7750784/
Abstract

BACKGROUND

COVID-19 is highly contagious, and the crude mortality rate could reach 49% in critical patients. Inflammation concerns on disease progression. This study analyzed blood inflammation indicators among mild, severe and critical patients, helping to identify severe or critical patients early.

METHODS

In this cross-sectional study, 100 patients were included and divided into mild, severe or critical groups according to disease condition. Correlation of peripheral blood inflammation-related indicators with disease criticality was analyzed. Cut-off values for critically ill patients were speculated through the ROC curve.

RESULTS

Significantly, disease severity was associated with age (R = -0.564, P < 0.001), interleukin-2 receptor (IL2R) (R = -0.534, P < 0.001), interleukin-6 (IL-6) (R = -0.535, P < 0.001), interleukin-8 (IL-8) (R = -0.308, P < 0.001), interleukin-10 (IL-10) (R = -0.422, P < 0.001), tumor necrosis factor α (TNFα) (R = -0.322, P < 0.001), C-reactive protein (CRP) (R = -0.604, P < 0.001), ferroprotein (R = -0.508, P < 0.001), procalcitonin (R = -0.650, P < 0.001), white cell counts (WBC) (R = -0.54, P < 0.001), lymphocyte counts (LC) (R = 0.56, P < 0.001), neutrophil count (NC) (R = -0.585, P < 0.001) and eosinophil counts (EC) (R = 0.299, P < 0.001). With IL2R > 793.5 U/mL or CRP > 30.7 ng/mL, the progress of COVID-19 to critical stage should be closely observed and possibly prevented.

CONCLUSIONS

Inflammation is closely related to severity of COVID-19, and IL-6 and TNFα might be promising therapeutic targets.

摘要

背景

COVID-19 具有高度传染性,重症患者的粗死亡率可达到 49%。炎症是影响疾病进展的关注点。本研究分析了轻症、重症和危重症患者的血液炎症指标,有助于早期识别重症或危重症患者。

方法

本横断面研究纳入 100 例患者,根据病情分为轻症、重症或危重症组。分析外周血炎症相关指标与疾病危重程度的相关性。通过 ROC 曲线推测危重症患者的截断值。

结果

疾病严重程度与年龄(R=-0.564,P<0.001)、白细胞介素-2 受体(IL-2R)(R=-0.534,P<0.001)、白细胞介素-6(IL-6)(R=-0.535,P<0.001)、白细胞介素-8(IL-8)(R=-0.308,P<0.001)、白细胞介素-10(IL-10)(R=-0.422,P<0.001)、肿瘤坏死因子-α(TNF-α)(R=-0.322,P<0.001)、C 反应蛋白(CRP)(R=-0.604,P<0.001)、铁蛋白(R=-0.508,P<0.001)、降钙素原(PCT)(R=-0.650,P<0.001)、白细胞计数(WBC)(R=-0.54,P<0.001)、淋巴细胞计数(LC)(R=0.56,P<0.001)、中性粒细胞计数(NC)(R=-0.585,P<0.001)和嗜酸性粒细胞计数(EC)(R=0.299,P<0.001)显著相关。IL-2R>793.5 U/mL 或 CRP>30.7ng/mL 时,COVID-19 进展为危重症阶段应密切观察并可能预防。

结论

炎症与 COVID-19 严重程度密切相关,IL-6 和 TNF-α可能是有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/901180c55be0/12879_2020_5681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/73b85c35dd9f/12879_2020_5681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/6ecac14697b6/12879_2020_5681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/e753c2fb204b/12879_2020_5681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/901180c55be0/12879_2020_5681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/73b85c35dd9f/12879_2020_5681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/6ecac14697b6/12879_2020_5681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/e753c2fb204b/12879_2020_5681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a13a/7751126/901180c55be0/12879_2020_5681_Fig4_HTML.jpg

相似文献

1
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.新型冠状病毒肺炎患者疾病严重程度与炎症相关参数的相关性分析:一项回顾性研究。
BMC Infect Dis. 2020 Dec 21;20(1):963. doi: 10.1186/s12879-020-05681-5.
2
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.新型冠状病毒病(COVID-19)不同严重程度的炎症和非炎症指标的差异。
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
3
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.白细胞介素-6、降钙素原和中性粒细胞与淋巴细胞比值:潜在的免疫炎症参数,可用于识别 COVID-19 的严重和致命形式。
Cytokine. 2021 May;141:155428. doi: 10.1016/j.cyto.2021.155428. Epub 2021 Jan 15.
4
Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.利用 IL-2R/淋巴细胞预测 COVID-19 患者的临床进展。
Clin Exp Immunol. 2020 Jul;201(1):76-84. doi: 10.1111/cei.13450. Epub 2020 May 15.
5
Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.中国武汉 143 例 COVID-19 患者的疾病严重程度与临床和生化特征的相关性分析:一项描述性研究。
BMC Infect Dis. 2020 Jul 16;20(1):519. doi: 10.1186/s12879-020-05242-w.
6
Association between serum inflammatory parameters and the disease severity in COVID-19 patients.血清炎症参数与 COVID-19 患者疾病严重程度的关系。
J Clin Lab Anal. 2022 Jan;36(1):e24162. doi: 10.1002/jcla.24162. Epub 2021 Dec 7.
7
Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.中性粒细胞与淋巴细胞比值,新冠肺炎患者疾病严重程度评估的关键预测指标。
Int J Lab Hematol. 2021 Apr;43(2):329-335. doi: 10.1111/ijlh.13374. Epub 2020 Oct 25.
8
Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.持续性淋巴细胞减少和白细胞介素 6 水平与 COVID-19 患者的死亡独立相关。
Clin Exp Med. 2023 Nov;23(7):3719-3728. doi: 10.1007/s10238-023-01114-0. Epub 2023 Jun 13.
9
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
10
sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.sTREM-1 预测 COVID-19 患者的疾病严重程度和死亡率:外周血白细胞和 MMP-8 活性的参与。
Viruses. 2021 Dec 15;13(12):2521. doi: 10.3390/v13122521.

引用本文的文献

1
Bridging the gap between CVD and COVID-19: the oxidized LDL hypothesis.弥合心血管疾病与新冠病毒疾病之间的差距:氧化型低密度脂蛋白假说。
Front Med (Lausanne). 2025 Aug 6;12:1588062. doi: 10.3389/fmed.2025.1588062. eCollection 2025.
2
The hidden dangers in routine medical complaints: uncovering patient harm.常规医疗投诉中的隐患:发现患者受到的伤害。
BMC Health Serv Res. 2025 Jul 18;25(1):957. doi: 10.1186/s12913-025-13105-w.
3
The protective effect of serum antibodies in preventing SARS-CoV-2 virus entry into cardiac muscle.血清抗体在预防新冠病毒进入心肌方面的保护作用。

本文引用的文献

1
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
2
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
3
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.
Physiol Res. 2024 Dec 31;73(S3):S715-S725. doi: 10.33549/physiolres.935475.
4
The Impact of Vaccination on COVID-19 Outcomes in Vietnam.疫苗接种对越南新冠疫情结局的影响
Diagnostics (Basel). 2024 Dec 18;14(24):2850. doi: 10.3390/diagnostics14242850.
5
Cytokine Storm among Bangladeshi adults with COVID-19: A prospective cohort study.孟加拉国新冠肺炎成年患者的细胞因子风暴:一项前瞻性队列研究。
Heliyon. 2024 Nov 19;10(23):e40532. doi: 10.1016/j.heliyon.2024.e40532. eCollection 2024 Dec 15.
6
Alterations in the expression of serum-derived exosome-enclosed inflammatory microRNAs in Covid-19 patients.新冠病毒肺炎患者血清来源外泌体包裹的炎性微小核糖核酸表达的改变
Heliyon. 2024 Oct 12;10(20):e39303. doi: 10.1016/j.heliyon.2024.e39303. eCollection 2024 Oct 30.
7
Cq values as an indicator for COVID-19 outcomes: A study of the correlation between laboratory parameters.Cq 值作为 COVID-19 结局的指标:实验室参数相关性研究。
Immun Inflamm Dis. 2024 Jun;12(6):e1326. doi: 10.1002/iid3.1326.
8
Inflammatory Biomarkers for Assessing In-Hospital Mortality Risk in Severe COVID-19-A Retrospective Study.用于评估重症新型冠状病毒肺炎住院死亡风险的炎症生物标志物——一项回顾性研究
J Pers Med. 2024 May 10;14(5):503. doi: 10.3390/jpm14050503.
9
Prioritizing Disease Diagnosis in Neonatal Cohorts through Multivariate Survival Analysis: A Nonparametric Bayesian Approach.通过多变量生存分析在新生儿队列中进行疾病诊断优先级排序:一种非参数贝叶斯方法。
Healthcare (Basel). 2024 May 2;12(9):939. doi: 10.3390/healthcare12090939.
10
[Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination].[炎症、营养不良与新型冠状病毒2感染:一种灾难性的组合]
Rev Clin Esp. 2020 Nov;220(8):511-517. doi: 10.1016/j.rce.2020.07.007. Epub 2020 Aug 24.
一组在中国武汉以外地区感染 2019 年新型冠状病毒(SARS-CoV-2)的患者的临床特征:回顾性病例系列。
BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
6
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.在重症监护环境中,使用生物标志物与临床决策来决定抗生素的开始和停止时的利弊。
Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21.